Donald E. Bobo Jr - Feb 11, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP,Strategy/Corp Development
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Feb 11, 2022
Transactions value $
-$991,476
Form type
4
Date filed
2/11/2022, 07:53 PM
Previous filing
Jan 31, 2022
Next filing
Mar 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $240K +11.1K +19.59% $21.76 67.4K Feb 11, 2022 Direct F1
transaction EW Common Stock Sale -$44.8K -400 -0.59% $112.00 67K Feb 11, 2022 Direct F1, F2
transaction EW Common Stock Sale -$1.19M -10.7K -15.88% $111.47 56.4K Feb 11, 2022 Direct F1, F3, F4
transaction EW Common Stock Gift $0 -7K -5.63% $0.00 117K Aug 10, 2021 By Trust
holding EW Common Stock 38.2K Feb 11, 2022 401(k) F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -11.1K -33.33% $0.00 22.1K Feb 11, 2022 Common Stock 11.1K $21.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $111.990 to $112.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $110.990 to $111.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4 Reflects a correction of a Bona fide gift previously filed for on January 31, 2022.
F5 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.